Skip to main content

Advertisement

Log in

Increased expression of IL12B mRNA transcribed from the risk haplotype for Crohn’s disease is a risk factor for disease relapse in Japanese patients

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

IL12B is a promising candidate for a susceptibility gene in Crohn’s disease (CD). The aim of this study was to perform a candidate gene analysis of IL12B in Japanese CD patients, investigate whether the genotype is associated with disease phenotypes, and determine how the risk allele affects susceptibility to CD.

Methods

Three hundred seventy-five patients with CD, 265 patients with ulcerative colitis, and 463 healthy controls were examined. Ten single-nucleotide polymorphisms (SNPs) around IL12B were genotyped. Case–control and subphenotype (including disease course) analyses were performed. The allelic expression ratio of IL12B messenger RNA (mRNA) was examined by a SNaPshot analysis in lipopolysaccharide-stimulated monocytes.

Results

Four SNPs located upstream of the IL12B gene were significantly associated with CD. A conditional analysis revealed that these associations included two independent signals tagged by IL12B_1 and IL12B_3 (P = 9.42 × 10−6 and  1.49 × 10−4 respectively). IL12B_3 was also associated with earlier relapse in CD (P = 0.0144). The allelic expression ratios of IL12B mRNA transcribed from the risk haplotype to the protective haplotype tagged by IL12B_3 in lipopolysaccharide-stimulated monocytes from ten healthy controls heterozygous for IL12B_3 were significantly higher than that of the respective genomic DNA (P = 0.00923). No SNP was associated with ulcerative colitis.

Conclusions

We confirmed the association of SNPs located upstream of IL12B with CD in Japanese patients. The demonstrated allelic expression imbalance supports the idea that the IL12B risk haplotype confers susceptibility not only to CD onset but to also relapse through increased IL12B mRNA expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. McGovern D, Kugathasan S, Cho JH. Genetics of inflammatory bowel diseases. Gastroenterology. 2015;149(5):1163–76.e2.

  3. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40(8):955–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci. Nat Genet. 2010;42(12):1118–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Brand S. Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut. 2009;58(8):1152–67.

    Article  CAS  PubMed  Google Scholar 

  7. Sandborn WJ, Feagan BG, Fedorak RN, et al. A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn’s disease. Gastroenterology. 2008;135(4):1130–41.

    Article  CAS  PubMed  Google Scholar 

  8. Sandborn WJ, Gasink C, Gao LL, et al. Ustekinumab induction and maintenance therapy in refractory Crohn’s disease. N Engl J Med. 2012;367(16):1519–28.

    Article  CAS  PubMed  Google Scholar 

  9. Yamazaki K, Takahashi A, Takazoe M, et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn’s disease in Japanese patients. Gut. 2009;58(2):228–32.

    Article  CAS  PubMed  Google Scholar 

  10. Marquez A, Mendoza JL, Taxonera C, et al. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. Inflamm Bowel Dis. 2008;14(9):1192–6.

    Article  PubMed  Google Scholar 

  11. Aiba Y, Yamazaki K, Nishida N, et al. Disease susceptibility genes shared by primary biliary cirrhosis and Crohn’s disease in the Japanese population. J Hum Genet. 2015;60(9):525–31.

    Article  CAS  PubMed  Google Scholar 

  12. Stanilova S, Miteva L. Taq-I polymorphism in 3′UTR of the IL-12B and association with IL-12p40 production from human PBMC. Genes Immun. 2005;6(4):364–6.

    Article  CAS  PubMed  Google Scholar 

  13. Seegers D, Zwiers A, Strober W, et al. A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 2002;3(7):419–23.

    Article  CAS  PubMed  Google Scholar 

  14. Morahan G, Huang D, Ymer SI, et al. Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat Genet. 2001;27(2):218–21.

    Article  CAS  PubMed  Google Scholar 

  15. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80(2):273–90.

    Article  CAS  PubMed  Google Scholar 

  16. Hacking D, Knight JC, Rockett K, et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun. 2004;5(4):274–82.

    Article  CAS  PubMed  Google Scholar 

  17. Ge B, Pokholok DK, Kwan T, et al. Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet. 2009;41(11):1216–22.

    Article  CAS  PubMed  Google Scholar 

  18. Dubinsky MC, Kugathasan S, Kwon S, et al. Multidimensional prognostic risk assessment identifies association between IL12B variation and surgery in Crohn’s disease. Inflamm Bowel Dis. 2013;19(8):1662–70.

    Article  PubMed  Google Scholar 

  19. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. de Bakker PI, Yelensky R, Pe’er I, et al. Efficiency and power in genetic association studies. Nat Genet. 2005;37(11):1217–23.

    Article  PubMed  Google Scholar 

  21. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5.

    Article  CAS  PubMed  Google Scholar 

  22. Morahan G, Huang D, Wu M, et al. Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet. 2002;360(9331):455–9.

    Article  CAS  PubMed  Google Scholar 

  23. Noguchi E, Yokouchi Y, Shibasaki M, et al. Identification of missense mutation in the IL12B gene: lack of association between IL12B polymorphisms and asthma and allergic rhinitis in the Japanese population. Genes Immun. 2001;2(7):401–3.

    Article  CAS  PubMed  Google Scholar 

  24. Control Wellcome Trust Case. C. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature. 2007;447(7145):661–78.

    Article  Google Scholar 

  25. Kakuta Y, Ueki N, Kinouchi Y, et al. TNFSF15 transcripts from risk haplotype for Crohn’s disease are overexpressed in stimulated T cells. Hum Mol Genet. 2009;18(6):1089–98.

    Article  CAS  PubMed  Google Scholar 

  26. Norton N, Williams NM, Williams HJ, et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet. 2002;110(5):471–8.

    Article  CAS  PubMed  Google Scholar 

  27. Fukuda Y, Koga M, Arai M, et al. Monoallelic and unequal allelic expression of the HTR2A gene in human brain and peripheral lymphocytes. Biol Psychiatry. 2006;60(12):1331–5.

    Article  CAS  PubMed  Google Scholar 

  28. Shimokawa N, Nishiyama C, Hirota T, et al. Functional analysis of a polymorphism in the promoter region of the IL-12/23p40 gene. Clin Exp Allergy. 2009;39(2):228–35.

    Article  CAS  PubMed  Google Scholar 

  29. Yilmaz V, Yentur SP, Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine. 2005;30(4):188–94.

    Article  CAS  PubMed  Google Scholar 

  30. Muller-Berghaus J, Kern K, Paschen A, et al. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun. 2004;5(5):431–4.

    Article  CAS  PubMed  Google Scholar 

  31. Buning C, Genschel J, Buhner S, et al. Mutations in the NOD2/CARD15 gene in Crohn’s disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther. 2004;19(10):1073–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank past and present members of the IBD Group for fruitful discussions and scientific contributions. This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Numbers JP26460959, JP15H04805, and JP15K15284.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoichi Kakuta.

Additional information

Yoichi Kakuta and Tomoya Kimura contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

535_2017_1322_MOESM1_ESM.pptx

Fig. S1. The calibration curve to measure the IL12B mRNA allelic expression ratio. The regression line was obtained with use of standard mixtures of DNA from two individuals homozygous for the IL12B_10 C and A alleles. The signal intensity (peak height) from SNaPshot was plotted against known ratios in mixed standard samples. The peak height ratios are mean values from three duplicate experiments (PPTX 45 kb)

Supplementary material 2 (DOCX 17 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kakuta, Y., Kimura, T., Negoro, K. et al. Increased expression of IL12B mRNA transcribed from the risk haplotype for Crohn’s disease is a risk factor for disease relapse in Japanese patients. J Gastroenterol 52, 1230–1239 (2017). https://doi.org/10.1007/s00535-017-1322-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-017-1322-5

Keywords

Navigation